Literature DB >> 15320948

Renal amyloidosis is associated with increased mortality in hemodialysis patients.

Sule Sengul1, Zubeyde Arat, F Nurhan Ozdemir.   

Abstract

AIM: The aim of the study was to investigate the risk factors for mortality of hemodialysis (HD) patients at Baskent University Hospital, HD Center in Ankara, Turkey.
METHODS: We prospectively followed 203 stable HD patients for 42 months. Population characteristics (age, gender, duration of HD, causes of end stage renal disease [ESRD]) and biochemical variables were included in the study. Mortality was prospectively monitored.
RESULTS: Sixty-one patients died over 42 months. Cardiovascular events and infections/septicemia were the most common causes of death. The nonsurvivors had significantly lower hemoglobin (Hb), parathyroid hormone (PTH), creatinine, albumin, and prealbumin levels and higher age and higher C-reactive protein (CRP) levels. Survival curves as obtained by the Kaplan-Meier method in the groups of causes of ESRD (renal amyloidosis [RA], diabetes mellitus [DM], hypertension [HT] + atherosclerotic kidney disease [AKD], and others) showed that patients with DM and RA had the worst prognosis during the follow-up period. In the multivariate Cox proportional hazards model, RA and DM were found to be independent risk factors for death in HD patients together with high CRP and low albumin and prealbumin levels. Infection/septicemia is the leading cause of mortality in patients with DM and RA.
CONCLUSION: The results of this study indicate that the presence of RA and DM as underlying renal diseases are independent predictors of mortality in our HD patients along with poor nutritional status and activated inflammatory response.

Entities:  

Mesh:

Year:  2004        PMID: 15320948     DOI: 10.1111/j.1525-1594.2004.00063.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  2 in total

1.  Prealbumin is associated with visceral fat mass in patients receiving hemodialysis.

Authors:  Alessio Molfino; Steven B Heymsfield; Fansan Zhu; Peter Kotanko; Nathan W Levin; Tjien Dwyer; George A Kaysen
Journal:  J Ren Nutr       Date:  2013-04-24       Impact factor: 3.655

2.  Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes.

Authors:  Andrea Henze; Katharina M Espe; Christoph Wanner; Vera Krane; Jens Raila; Berthold Hocher; Florian J Schweigert; Christiane Drechsler
Journal:  Diabetes Care       Date:  2012-08-24       Impact factor: 19.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.